69998-14-7

Basic information

• Product Name: 1-(propan-2-yl)pyrimidine-2,4,6(1H,3H,5H)-trione
• Synonyms: Isopropylbarbituric acid
• CAS NO: 69998-14-7
• Molecular Formula: C₇H₁₀N₂O₃
• Molecular Weight: 170.1659
• Mol File: 69998-14-7.mol
• Article Data: 7

Chemical Properties

• Density: 1.259g/cm³
• Refractive Index: 1.498
• CAS DataBase Reference: 1-(propan-2-yl)pyrimidine-2,4,6(1H,3H,5H)-trione(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(propan-2-yl)pyrimidine-2,4,6(1H,3H,5H)-trione(69998-14-7)
• EPA Substance Registry System: 1-(propan-2-yl)pyrimidine-2,4,6(1H,3H,5H)-trione(69998-14-7)

Safety Data

• Hazardous Substances Data: 69998-14-7(Hazardous Substances Data)

Usage

General Description

1-(propan-2-yl)pyrimidine-2,4,6(1H,3H,5H)-trione is a chemical compound with the molecular formula C8H12N2O3. It is a pyrimidine derivative with a unique trione functional group, which consists of three carbonyl groups attached to the pyrimidine ring. 1-(propan-2-yl)pyrimidine-2,4,6(1H,3H,5H)-trione is commonly used in organic synthesis and pharmaceutical research as a building block for more complex molecules. It also has potential applications in the development of new drugs and therapeutic agents due to its structural features and reactivity. Additionally, 1-(propan-2-yl)pyrimidine-2,4,6(1H,3H,5H)-trione may also have other industrial and research uses, making it a versatile and valuable chemical compound in various fields.

Upstream product

• 691-60-1 N-isopropylurea 
• 108-59-8 malonic acid dimethyl ester 
• 105-53-3 diethyl malonate 

Relevant articles and documents

-

-

Myosin inhibitor, as well as preparation method and application thereof

The invention relates to the field of medicinal chemistry, in particular to a myosin inhibitor, as well as a preparation method and application thereof. The invention provides a compound or pharmacologically acceptable salt, an isomer, a prodrug, a polymorphic substance or a solvate thereof. A chemical structural formula of the compound is as shown in a formula I. Compared with other similar medicines in the prior art, the compound or the pharmacologically acceptable salt, the isomer, the prodrug, the polymorphic substance or the solvate thereof provided by the invention have better activity and a more ideal pharmacokinetics characteristic.

BICYCLIC-PYRIMIDINEDIONE COMPOUNDS

The present invention provides novel bicyclic pyrimidinedione compounds that are useful for the treatment of hypertrophic cardiomyopathy (HCM) and conditions associated with left ventricular hypertrophy or diastolic dysfunction. The synthesis and characterization of the compounds is described, as well as methods for treating HCM and other forms of heart disease.